InspireMD Reports Prelim. Cumulative 3-Year Follow-Up Safety, Efficacy, Stroke Prevention Durability Data From CGuard Trial: 'data showed no stroke or stroke-related deaths between 24 and 36 months...'
Benzinga Newsdesk